Bank of Queensland has kicked off the bank reporting season, with Macquarie, ANZ, NAB and Westpac to follow. Analysts discuss what they’re looking for.
Tabcorp beat most market expectations with a strong March quarter revenue result, brokers generally continuing to see value leading into the upcoming de-merger vote.
Small-cap stocks offer potential outperformance, and analysts are favouring industrials over resource companies as investors shift focus to overlooked value.
Shares in CSG limited have performed poorly over the past 12 months but stockbrokers have started to turn more positive on the company.
The sale of Marathon Tyres completes the divestment of non-core assets at Alesco and brokers sees upside from a more-focused business going forward.
Morningstar has ceased coverage on biotech Circadian Technologies, but the broker notes the upside potential story remains intact.
Citi has increased its iron ore price forecasts out to 2020 but little has found its way to producer earnings forecasts given rising costs and project risk.
Ramsay Health Care announced the purchase of a hospital in France and a successful tender for another hospital in Queensland but the good news is tempered by a full valuation, say stockbrokers.
Today’s RBA statement accompanying the predictable lack of change to the cash rate is barely changed from last month despite world events.
The AIG-CBA Performance of Services Index declined again in March, highlighting ongoing caution among Australian consumers with respect to the economic outlook.